Cash distributions per share
|Year||Amount in CHF||Ex-date||Payment date|
* Proposal to the Ordinary Shareholders' Meeting on 22 June 2020.
Based on the notifications received by the Company, the following shareholders reported equity holdings in HBM Healthcare Investments Ltd of three percent or more as at 31 March 2019:
|15 - 20%||Nogra Pharma Invest S.à.r.l., Luxemburg|
See here for details about significant shareholders in HBM Healthcare Investments Ltd. (SIX Swiss Exchange).
Management fees (paid quarterly):
0.75% of company assets plus
0.75% of the company's market capitalisation
Performance fee (paid annually):
15% on increase in value above the high water mark. High water mark (per share for all outstanding shares) for financial year 2020/2021: NAV of CHF 212.03.
See here for details about Management transactions in HBM Healthcare Investments' shares (SIX Swiss Exchange).
Articles of association
Share buy-back programmes
Share buy-back programme 2019
The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 1'203 shares.
Share buy-back programme 2016 (completed)
The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 2'389 shares.